Most Recent Articles about LLY
J&J's Erdafitinib Gets FDA Approval for Urothelial Cancer http://www.zacks.com/stock/news/380671/jjs-erdafitinib-gets-fda-approval-for-urothelial-cancer?cid=CS-ZC-FT-380671 Apr 15, 2019 - FDA grants approval to J&J's (JNJ) erdafitinib for metastatic urothelial cancer, a type of bladder cancer. This is J&J's second FDA approval for a new drug in less than two months
Top Stock Reports for Eli Lilly, Altria & Becton Dickinson http://www.zacks.com/research-daily/376965/top-stock-reports-for-eli-lilly-altria-becton-dickinson?cid=CS-ZC-FT-376965 Apr 10, 2019 - Top Stock Reports for Eli Lilly, Altria & Becton Dickinson
Why Eli Lilly (LLY) is a Great Dividend Stock Right Now http://www.zacks.com/stock/news/376824/why-eli-lilly-lly-is-a-great-dividend-stock-right-now?cid=CS-ZC-FT-376824 Apr 10, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eli Lilly (LLY) have what it takes? Let's find out.

Related Companies

Name Exchange Price Mkt Cap
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
SNY Sanofi NYSE $43.75 $109.14B
ABT Abbott Laboratories NYSE $67.67 $118.71B
BMY Bristol-Myers Squibb Company NYSE $61.3 $100.03B
GSK GlaxoSmithKline PLC NYSE $39.21 $97.25B
Sector: Health Care > Industry: Major Pharmaceuticals